REFERENCES
- Bahrami H. Causal inference in primary open angle glaucoma: specific discussion on intraocular pressure. Ophthalmic Epidemiology. 2006; 283–289
- Kass M A, Heuer D K, Higginbotham E J, Johnson C A, Keltner J L, Miller J P. The Ocular Hypertension Treatment Study—A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology 2002; 120: 701–713, [INFOTRIEVE], [CSA]
- Leibowitz H M, Krueger D E, Maunder L R, Milton R C, Kini M M, Kahn H A. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 1980; 24: 335–610, [INFOTRIEVE], [CSA], [CROSSREF]
- Gordon M O, Kass M A. The ocular hypertension treatment study—Design and baseline description of the participants. Archives of Ophthalmology 1999; 117: 573–583, [INFOTRIEVE], [CSA]
- Stromberg U. Ocular hypertension—frequency, course, and relation to other disorders occurring in glaucoma, as seen from mass survey of all inhabitants over 40 years of age in a Swedish town. Acta Ophthalmologica 1962; 69: 1–75, suppl[INFOTRIEVE], [CSA]
- Friedman D S, Wilson M R, Liebmann J M, Fechtner R D, Weinreb R N. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. American Journal of Ophthalmology 2004; 138: S19–S31, [INFOTRIEVE], [CSA], [CROSSREF]
- Weinreb R N, Friedman D S, Fechtner R D, Cioffi G A, Coleman A L, Girkin C A. Risk assessment in the management of patients with ocular hypertension. American Journal of Ophthalmology 2004; 138: 458–467, [INFOTRIEVE], [CSA], [CROSSREF]
- Charlton B G. Attribution of causation in epidemiology: chain or mosaic?. Journal of Clinical Epidemiology. 1996; 49: 105–107, [INFOTRIEVE], [CSA], [CROSSREF]
- Stehbens W E. The concept of cause in disease. Journal of Chronic Diseases 1985; 38: 947–950, [INFOTRIEVE], [CSA], [CROSSREF]
- Greenland S, Brumback B. An overview of relations among causal modelling methods. International Journal of Epidemiology 2002; 31: 1030–1037, [INFOTRIEVE], [CSA], [CROSSREF]
- Rothman K J, Greenland S. Modern Epidemiology, 2nd ed. Lippincott, Philadelphia 1998
- Sobel M E. Causal inference in the social sciences. Journal of the American Statistical Association 2000; 95: 647–651, [CSA], [CROSSREF]
- Kaufman J S, Kaufman S. Assessment of structured socioeconomic effects on health. Epidemiology 2001; 12: 157–167, [INFOTRIEVE], [CSA], [CROSSREF]
- Maldonado G, Greenland S. Estimating causal effects (with discussion). International Journal of Epidemiology 2002; 12: 157–167, [CSA]
- Greenland S, Pearl J, Robins J M. Causal diagrams for epidemiologic research. Epidemiology 1999; 10: 37–48, [INFOTRIEVE], [CSA], [CROSSREF]
- Robins J M. Data, design, and background knowledge in etiologic inference. Epidemiology 2001; 12: 313–320, [INFOTRIEVE], [CSA], [CROSSREF]
- Nakla M, Caprioli J, Morgan J A. Glaucomatous optic neuropathy. Glaucoma: Science and Practice, J C Morrison, I P Pollak. Thieme, New York 2003
- Hernandez M R, Andrzejewska W M, Neufled A H. Changes in the extracellular-matrix of the human optic-nerve head in primary open angle glaucoma. American Journal of Ophthalmology 1990; 109: 180–188, [INFOTRIEVE], [CSA]
- Pena J DO, Agapova O, Gabelt B AT, Levin L A, Lucarelli M J, Kaufman P L. Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure. Investigative Ophthalmology & Visual Science 2001; 42: 2303–2314, [CSA]
- Yan X M, Tezel G, Wax M B, Edward D P. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Archives of Ophthalmology 2000; 118: 666–673, [INFOTRIEVE], [CSA]
- Quigley H A, Hohman R M, Addicks E M, Massof R W, Green W R. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. American Journal of Ophthalmology 1983; 95: 673–691, [INFOTRIEVE], [CSA]
- Quigley H A, Brown A, Dormanpease M E. Alterations in elastin of the optic-nerve head in human and experimental glaucoma. British Journal of Ophthalmology 1991; 75: 552–557, [INFOTRIEVE], [CSA]
- Quigley H, Pease M E, Thibault D. Change in the appearance of elastin in the lamina-cribrosa of glaucomatous optic-nerve heads. Graefes Archive for Clinical and Experimental Ophthalmology 1994; 232: 257–261, [CSA]
- Hernandez M R, Ye H Q. Glaucoma—Changes in extracellular-matrix in the optic-nerve head. Annals of Medicine 1993; 25: 309–315, [INFOTRIEVE], [CSA]
- Davanger M, Ringvold A, Blika S. Pseudo-exfoliation, IOP, and Glaucoma. Acta Ophthalmologica 1991; 69: 569–573, [INFOTRIEVE], [CSA]
- Rothman K J. Causes. American Journal of Epidemiology 1976; 104: 587–592, [INFOTRIEVE], [CSA]
- Davanger M, Ringvold A, Blika S. The probability of having glaucoma at different IOP levels. Acta Ophthalmol (Copenh) 1991; 69: 565–568, [CSA]